Search dm+d | This AMP cannot be matched against our prescribing data.
Description | Arexvy vaccine powder and suspension for suspension for injection 0.5ml vials (GlaxoSmithKline UK Ltd) |
BNF code | 1404000AWBBAAAA |
Virtual Medicinal Product | Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted) powder and suspension for suspension for injection 0.5ml vials |
Name | Arexvy vaccine powder and suspension for suspension for injection 0.5ml vials |
Abbreviated name | Arexvy vaccine inj 0.5ml vials |
Supplier | GlaxoSmithKline UK Ltd |
Current licensing authority | Medicines - MHRA/EMA |
EMA additional monitoring | ✓ |
Parallel import | ✗ |
Restrictions on availability | Restricted Availability |
Licensed Route | |
---|---|
Licenced route | Intramuscular |
Actual Medicinal Product Packs | |
Arexvy vaccine powder and suspension for suspension for injection 0.5ml vials (GlaxoSmithKline UK Ltd) 1 vial |
dm+d data retrieved from TRUD: release NHSBSA_6.3.0_20240624000001, imported on 24th June 2024 at 05:06:11.